Golden Cross Gives Bulls Green Light?
One of the more unexpected tailwinds for healthcare stocks in recent years has been the weight-loss frenzy brought about most notably by Ozempic.
Novo Nordisk’s drug was such a hit that the share price soared by 62% over the past year alone. Yet it’s not the only game in town. Eli Lilly’s weight-loss drug, Mounjaro has shown promising results in clinical trials for weight loss too. » Read more about: Golden Cross Gives Bulls Green Light? »
Read More
Alert: Stunning Pharma Stock 32.7% Undervalued
Investment Alert: Buy McKesson (MCK) Under $370/share
Disclaimer: Investment Alerts have a medium to long-term time horizon. These do not constitute financial advice and you should contact a financial advisor before deciding whether it is appropriate for your individual circumstances.
There’s lots to like about McKesson.
» Read more about: Alert: Stunning Pharma Stock 32.7% Undervalued »
Read More
Market Commentary: 4 Reasons Why Buffett Bet 43% Of His Portfolio On 1 Stock
When you understand that stocks are not just prices on a chart but businesses, investing gets much easier. You take your eyes off solely viewing price undulations and focus more on the nuts and bolts of the business driving the share price.
One business with such extraordinary attributes that Warren Buffett bet over 43% of his holdings in it is Apple.
» Read more about: Market Commentary: 4 Reasons Why Buffett Bet 43% Of His Portfolio On 1 Stock »
Read More
Market Commentary: Undervalued Zombie with 41.6% Upside
Zombie companies are heavily indebted but continue to operate and service their debts, though usually they don’t pay them off. Because they’re so heavily indebted, small changes in interest rates can make them vulnerable to bankruptcy. So you might be wondering, why, in a rising interest rate environment they should even cross our radar.
Well,
» Read more about: Market Commentary: Undervalued Zombie with 41.6% Upside »
Read More
1 Under-the-Radar Small Cap Set To Pop?
Applied Optoelectronics (NASDAQ: AAOI) isn’t well known and why would it be trading at less than a half a billion dollars in valuation. But it has seen a surge recently in insider buying as those in-the-know seem to be betting on future prospects.
This small-cap company has positioned itself as a critical supplier to major data center operators and telecommunications firms,
» Read more about: 1 Under-the-Radar Small Cap Set To Pop? »
Read MoreThe Burst
In 35 Days, The Stock Market Will…
Some forecasters are more famous and some are infamous. Martin Armstrong may well fall more into the latter than the former category. He is the creator of the Economic Confidence Model and has a storied past, including battling the government.
As the narrative goes, Martin built a software that could accurately identify major market trends and turning points,
» Read more about: In 35 Days, The Stock Market Will… »
Read MoreThe Spotlight
Market Commentary: Forget Apple, Uncle Sam Pays More
Apple made a splash recently with its announcement that iPhone users who have an Apple Card are now eligible to earn up to 4.15% annually. The announcement came as a shot across the bow to the already fragile banking industry. After all, who is more trusted than Apple with its fortress balance sheet to hold your money in a safe place?
» Read more about: Market Commentary: Forget Apple, Uncle Sam Pays More »
Read MoreThe Daily
Why This High-Yield Warren Buffett Stock Is Falling This Week
Since last Friday, shares of the digital audio company Sirius XM Holdings (SIRI -3.06%) are now trading 13.5% lower as of 1:52 p.m. ET Thursday. Sirius, a stock Warren Buffett’s Berkshire Hathaway has been piling into, fell after the company’s chief financial officer (CFO) spoke about concerns for the sector.
» Read more about: Why This High-Yield Warren Buffett Stock Is Falling This Week »